Style | Citing Format |
---|---|
MLA | Amini P, et al.. "Imperatorin Attenuates the Proliferation of Mcf-7 Cells in Combination With Radiotherapy or Hyperthermia." Current Radiopharmaceuticals, vol. 15, no. 3, 2022, pp. 236-241. |
APA | Amini P, Nodooshan SJ, Ashrafizadeh M, Aliasgharzadeh A, Vakili Z, Tavakoli S, Aryafar T, Musa AE, Najafi M, Taeb S, Farhood B (2022). Imperatorin Attenuates the Proliferation of Mcf-7 Cells in Combination With Radiotherapy or Hyperthermia. Current Radiopharmaceuticals, 15(3), 236-241. |
Chicago | Amini P, Nodooshan SJ, Ashrafizadeh M, Aliasgharzadeh A, Vakili Z, Tavakoli S, Aryafar T, et al.. "Imperatorin Attenuates the Proliferation of Mcf-7 Cells in Combination With Radiotherapy or Hyperthermia." Current Radiopharmaceuticals 15, no. 3 (2022): 236-241. |
Harvard | Amini P et al. (2022) 'Imperatorin Attenuates the Proliferation of Mcf-7 Cells in Combination With Radiotherapy or Hyperthermia', Current Radiopharmaceuticals, 15(3), pp. 236-241. |
Vancouver | Amini P, Nodooshan SJ, Ashrafizadeh M, Aliasgharzadeh A, Vakili Z, Tavakoli S, et al.. Imperatorin Attenuates the Proliferation of Mcf-7 Cells in Combination With Radiotherapy or Hyperthermia. Current Radiopharmaceuticals. 2022;15(3):236-241. |
BibTex | @article{ author = {Amini P and Nodooshan SJ and Ashrafizadeh M and Aliasgharzadeh A and Vakili Z and Tavakoli S and Aryafar T and Musa AE and Najafi M and Taeb S and Farhood B}, title = {Imperatorin Attenuates the Proliferation of Mcf-7 Cells in Combination With Radiotherapy or Hyperthermia}, journal = {Current Radiopharmaceuticals}, volume = {15}, number = {3}, pages = {236-241}, year = {2022} } |
RIS | TY - JOUR AU - Amini P AU - Nodooshan SJ AU - Ashrafizadeh M AU - Aliasgharzadeh A AU - Vakili Z AU - Tavakoli S AU - Aryafar T AU - Musa AE AU - Najafi M AU - Taeb S AU - Farhood B TI - Imperatorin Attenuates the Proliferation of Mcf-7 Cells in Combination With Radiotherapy or Hyperthermia JO - Current Radiopharmaceuticals VL - 15 IS - 3 SP - 236 EP - 241 PY - 2022 ER - |